share_log

CVS Health | 4: Statement of changes in beneficial ownership of securities-Officer Shah Prem S

CVS Health | 4: Statement of changes in beneficial ownership of securities-Officer Shah Prem S

西维斯健康 | 4:持股变动声明-高管 Shah Prem S
美股SEC公告 ·  12/04 06:17

牛牛AI助手已提取核心信息

Shah Prem S, EVP and Group President of CVS Health, completed a stock transaction on 11/30/2024. The transaction involved the sale of common stock, restricted common stock, ESOP common stock, and deferred stock units. Following the transaction, Shah Prem S holds 42,343.677 shares of common stock, 37,057 shares of restricted common stock, 4,968.7985 shares of ESOP common stock, and 3,468.315 deferred stock units. All shares are held directly. This transaction reflects a strategic decision by the executive, impacting his overall shareholding in CVS Health. Investors may consider this action when evaluating the company's stock performance and executive confidence in the company's future prospects.
Shah Prem S, EVP and Group President of CVS Health, completed a stock transaction on 11/30/2024. The transaction involved the sale of common stock, restricted common stock, ESOP common stock, and deferred stock units. Following the transaction, Shah Prem S holds 42,343.677 shares of common stock, 37,057 shares of restricted common stock, 4,968.7985 shares of ESOP common stock, and 3,468.315 deferred stock units. All shares are held directly. This transaction reflects a strategic decision by the executive, impacting his overall shareholding in CVS Health. Investors may consider this action when evaluating the company's stock performance and executive confidence in the company's future prospects.
CVS Health执行副总裁兼集团总裁Shah Prem S于2024年11月30日完成了股票交易。该交易涉及普通股、限制性普通股、ESOP普通股和递延股票单位的出售。 交易完成后,Shah Prem S持有42,343.677股普通股、37,057股限制性普通股、4,968.7985股ESOP普通股和3,468.315股递延股票单位。所有股份均直接持有。 该交易反映了该高管的战略决策,影响了他在CVS Health的总股权。投资者在评估公司的股票表现和高管对公司未来前景的信心时可以考虑这一行动。
CVS Health执行副总裁兼集团总裁Shah Prem S于2024年11月30日完成了股票交易。该交易涉及普通股、限制性普通股、ESOP普通股和递延股票单位的出售。 交易完成后,Shah Prem S持有42,343.677股普通股、37,057股限制性普通股、4,968.7985股ESOP普通股和3,468.315股递延股票单位。所有股份均直接持有。 该交易反映了该高管的战略决策,影响了他在CVS Health的总股权。投资者在评估公司的股票表现和高管对公司未来前景的信心时可以考虑这一行动。

译文内容由第三方软件翻译。


牛牛AI助手部分由第三方人工智能模型基于资讯内容自动生成。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。